Detailansicht

Wissensnetz

Person

Heike L. Pahl (1966-)

Ärztin

Name	Heike L. Pahl
Zeit	1966- (Lebensdaten)
Ort	Boston, Mass. (Geburtsort) USA
Beruf	Ärztin (charakteristischer Beruf)
Variante	Heike Luise Pahl Heike-L. Pahl Heike Luise Pahl-Hartl
Beziehung	Universitätsklinikum Freiburg. Klinik für Innere Medizin I Hämatologie (Thema) Molekulare Medizin (Thema) Anästhesiologie (Thema)
Weitere Angaben	Diss. Medizinische Fakultät Professur für Molekulare Hämatologie am Klinikum der Albert-Ludwigs-Universität Freiburg
Quelle	https://www.uniklinik-freiburg.de/medizin1/forschung/experimentelle-forschung/sektion-molekulare-haematologie/prof-dr-heike-l-pahl.html (Stand: 07.10.2016)
Datensatztyp	Person
GND-Nummer	12022772X
Datensatz-ID	12022772X
Beteiligt an alle anzeigen Characterization of the immunosuppressive tumour microenvironment in a mouse model of clear cell renal cell carcinoma GPRC5C drives branched-chain amino acid metabolism in leukemogenesis Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial The histone demethylase JMJD2C constitutes a novel NFE2 target gene that is required for the survival of JAK2V617F mutated cells DNA methylation and its role in heart development New C3H KitN824K/WT cancer mouse model develops late-onset malignant mammary tumors with high penetrance Noninvasive CNS lymphoma risk stratification and brain cancer classification by circulating tumor DNA profiling Kidney dysfunction is associated with thrombosis and disease severity in myeloproliferative neoplasms: implications from the German study group for MPN bioregistry Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry Pharmacological inhibition of Insulin Growth Factor-1 Receptor (IGF-1R) alone or in combination with ruxolitinib shows therapeutic efficacy in preclinical myeloproliferative neoplasm models The cross marks the spot: the emerging role of JmjC domain-containing proteins in myeloid malignancies Jmjd1c is dispensable for healthy adult hematopoiesis and Jak2V617F-driven myeloproliferative disease initiation in mice The role of histone demathylase JMJD1C in the pathophysiology of myeloproliferative neoplasms Water pipe smoking as a cause of secondary erythrocytosis LSD1 inhibition prolongs survival in mouse models of MPN by selectively targeting the Disease Clone Polycythaemia vera: Retrospektive Analyse klinischer und molekularer Parameter bei einer Kohorte von 131 Patienten Myeloproliferative neoplasms: cause, mechanism and treatment The role of Jmjd1c in murine embryonic development Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo The hen or the egg: inflammatory aspects of murine MPN models Charakterisierung der Lymphom-initiierenden Zellpopulation und Analyse von CD30 als kritische Zielstruktur des systemischen großzellig anaplastischen Lymphoms Der Transkriptionsfaktor NF-E2 und seine Rolle in der Pathogenese eines Phänotyps in der Milz im myeloproliferativen Mausmodell in vivo Mutationen im Transkriptionsfaktor NF-E2 und deren Rolle in der Entwicklung myeloproliferativer Neoplasien Untersuchung der Zellzyklus-abhängigen Regulation des proapoptotischen Proteins Bim A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2 Biological effects of NF-E2 overexpression in hematopoietic stem cells = Biologische Effekte der NF-E2 Überexpression in hämatopoietischen Stammzellen Characterization of a mouse model overexpressing transcription factor NF-E2 = Characterisierung eines Maus Modell mit einer Überexpression von NF-E2 Der Transkriptionsfaktor NF-E2 und seine Rolle in der Pathogenese myeloproliferativer Erkrankungen in vivo Überexpression des Transkriptionsfaktors NF-E2 in vivo, Etablierung eines neuen Modells zur Untersuchung und Therapie myeloproliferativer Neoplasien Signaltransduktion durch den Transkriptionsfaktor NF-κB [NF Kappa B]

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Heike L. Pahl (1966-)

Characterization of the immunosuppressive tumour microenvironment in a mouse model of clear cell renal cell carcinoma

GPRC5C drives branched-chain amino acid metabolism in leukemogenesis

Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial

The histone demethylase JMJD2C constitutes a novel NFE2 target gene that is required for the survival of JAK2V617F mutated cells

DNA methylation and its role in heart development

New C3H KitN824K/WT cancer mouse model develops late-onset malignant mammary tumors with high penetrance

Noninvasive CNS lymphoma risk stratification and brain cancer classification by circulating tumor DNA profiling

Kidney dysfunction is associated with thrombosis and disease severity in myeloproliferative neoplasms: implications from the German study group for MPN bioregistry

Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry

Pharmacological inhibition of Insulin Growth Factor-1 Receptor (IGF-1R) alone or in combination with ruxolitinib shows therapeutic efficacy in preclinical myeloproliferative neoplasm models

The cross marks the spot: the emerging role of JmjC domain-containing proteins in myeloid malignancies

Jmjd1c is dispensable for healthy adult hematopoiesis and Jak2V617F-driven myeloproliferative disease initiation in mice

The role of histone demathylase JMJD1C in the pathophysiology of myeloproliferative neoplasms

Water pipe smoking as a cause of secondary erythrocytosis

LSD1 inhibition prolongs survival in mouse models of MPN by selectively targeting the Disease Clone

Polycythaemia vera: Retrospektive Analyse klinischer und molekularer Parameter bei einer Kohorte von 131 Patienten

Myeloproliferative neoplasms: cause, mechanism and treatment

The role of Jmjd1c in murine embryonic development

Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo

The hen or the egg: inflammatory aspects of murine MPN models

Charakterisierung der Lymphom-initiierenden Zellpopulation und Analyse von CD30 als kritische Zielstruktur des systemischen großzellig anaplastischen Lymphoms

Der Transkriptionsfaktor NF-E2 und seine Rolle in der Pathogenese eines Phänotyps in der Milz im myeloproliferativen Mausmodell in vivo

Mutationen im Transkriptionsfaktor NF-E2 und deren Rolle in der Entwicklung myeloproliferativer Neoplasien

Untersuchung der Zellzyklus-abhängigen Regulation des proapoptotischen Proteins Bim

A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2

Biological effects of NF-E2 overexpression in hematopoietic stem cells = Biologische Effekte der NF-E2 Überexpression in hämatopoietischen Stammzellen

Characterization of a mouse model overexpressing transcription factor NF-E2 = Characterisierung eines Maus Modell mit einer Überexpression von NF-E2

Der Transkriptionsfaktor NF-E2 und seine Rolle in der Pathogenese myeloproliferativer Erkrankungen in vivo

Überexpression des Transkriptionsfaktors NF-E2 in vivo, Etablierung eines neuen Modells zur Untersuchung und Therapie myeloproliferativer Neoplasien

Signaltransduktion durch den Transkriptionsfaktor NF-κB [NF Kappa B]